<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00342524</url>
  </required_header>
  <id_info>
    <org_study_id>999905192</org_study_id>
    <secondary_id>05-I-N192</secondary_id>
    <nct_id>NCT00342524</nct_id>
  </id_info>
  <brief_title>Collection of Convalescent SARS Plasma by Apheresis</brief_title>
  <official_title>Collection of Convalescent SARS Plasma by Apheresis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect plasma by apheresis from patients who have recovered&#xD;
      from Severe Acute Respiratory Syndrome (SARS). This plasma will be processed into a&#xD;
      SARS-antibody enriched intravenous immune globulin (IVIG) product. This product will then be&#xD;
      available for use in a clinical trial if a SARS epidemic recurs.&#xD;
&#xD;
      Potentially eligible participants are people between 18 and 56 years of age who have&#xD;
      recovered from SARS. Potential participants will undergo three sequential screenings to&#xD;
      determine their eligibility for this study. Eligible participants will then be scheduled for&#xD;
      plasmapheresis. After apheresis, additional testing will be performed on a sample of the&#xD;
      source plasma. Once the sample has been tested and cleared, the source plasma will be shipped&#xD;
      to the United States to the storage facility and finally to the site of manufacturing of the&#xD;
      IVIG product. Participants may donate plasma again after 14 days.&#xD;
&#xD;
      The study will not have a direct benefit for participants. However, participation may help&#xD;
      develop a treatment that could be useful to other people who become infected with SARS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Beginning in February 2003, there was an outbreak with a novel coronavirus causing an&#xD;
      atypical pneumonia, subsequently referred to as Severe Acute Respiratory Syndrome (SARS).&#xD;
      This syndrome is associated with a high mortality rate and has no proven treatment. There is,&#xD;
      however, some evidence that treatment with convalescent plasma was beneficial.&#xD;
&#xD;
      The primary purpose of this protocol is to collect plasma by apheresis from patients that&#xD;
      recovered from SARS, and process this plasma into a high titer anti-SARS intravenous immune&#xD;
      globulin (IVIG). This will be a collaboration between the National Institute of Allergy and&#xD;
      Infectious Diseases and the Chinese University of Hong Kong. Cangene Corporation has been&#xD;
      contracted to manufacture the collected plasma in the United States (U.S.) into an IVIG&#xD;
      product, which can then be used for pre-clinical efficacy studies under an IND in a clinical&#xD;
      trial if SARS recurs. It is intended that the treatment trial would be conducted in Hong Kong&#xD;
      and/or the U.S., as well as any other place the disease recurs.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 6, 2005</start_date>
  <completion_date>February 8, 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Severe Acute Respiratory Syndrome</condition>
  <condition>SARS</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
        RECOVERED SARS SCREENING - INCLUSION CRITERIA (ALL OF THE FOLLOWING):&#xD;
&#xD;
          1. Clinical diagnosis of SARS occurring greater than or equal to 3 months prior to&#xD;
             screening. (objective documentation of SARS is not necessary)&#xD;
&#xD;
          2. The ability to understand and willingness to sign a written consent form and comply&#xD;
             with study requirements and procedures.&#xD;
&#xD;
        SARS APHERESIS SCREENING - INCLUSION CRITERIA (ALL OF THE FOLLOWING):&#xD;
&#xD;
          1. SARS Ab level greater than or equal to 1:80&#xD;
&#xD;
          2. Adequate clinical parameters (must meet all of the criteria below):&#xD;
&#xD;
               1. Afebrile (temperature less than 38 degrees C)&#xD;
&#xD;
               2. Systolic blood pressure greater than 100 and less than 160 mmHg&#xD;
&#xD;
               3. Diastolic blood pressure greater than 50 and less than 100 mmHg&#xD;
&#xD;
               4. Heart rate between 50-100 beats/minute&#xD;
&#xD;
               5. Weight greater than or equal to 110 pounds (50kg)&#xD;
&#xD;
          3. Adequate laboratory parameters (must meet all of the criteria below):&#xD;
&#xD;
               1. Hemoglobin greater than or equal to 12.5 g/dL for females or 13 grams/dL for&#xD;
                  males&#xD;
&#xD;
               2. HCT greater than or equal to 38%&#xD;
&#xD;
               3. Platelets greater than or equal to 150,000 x 10(3)/microL&#xD;
&#xD;
               4. Total serum protein greater than or equal to 6.0 grams/100 milliliters of blood&#xD;
&#xD;
               5. ALT less than 1.5 Upper limit of normal&#xD;
&#xD;
               6. Quantitative immune globulin levels (all of the following):&#xD;
&#xD;
                    -  Ig A greater than or equal to 90 mg/dL&#xD;
&#xD;
                    -  Ig G greater than or equal to 650 mg/dL&#xD;
&#xD;
                    -  Ig M greater than or equal to 35 mg/dL&#xD;
&#xD;
          4. Negative tests for blood borne pathogens (must meet all of the criteria below):&#xD;
&#xD;
               1. Human Immunodeficiency Virus 1/2 Antibody (Anti-HIV1/2) negative&#xD;
&#xD;
               2. Hepatitis B virus surface antigen (HBsAg) negative&#xD;
&#xD;
               3. Hepatitis C virus antibody (anti-HCV) negative&#xD;
&#xD;
               4. RPR non-reactive&#xD;
&#xD;
               5. HTLV antibody&#xD;
&#xD;
          5. Adequate peripheral venous access for plasmapheresis (as judged by the examiner)&#xD;
&#xD;
        DAY OF DONATION SCREENING - INCLUSION CRITERIA:&#xD;
&#xD;
          1. Afebrile (temperature less than 38 degrees C)&#xD;
&#xD;
          2. Systolic blood pressure greater than 100 and less than 160 mmHg&#xD;
&#xD;
          3. Diastolic blood pressure greater than 50 and less than 100 mmHg&#xD;
&#xD;
          4. Heart rate between 50-100 beats/minute&#xD;
&#xD;
          5. Blood hemoglobin level of greater than or equal to 12.5 grams/dL for females or 13&#xD;
             grams/dL for males&#xD;
&#xD;
          6. Total serum protein greater than or equal to 6.0 grams/100 milliliters of blood&#xD;
&#xD;
          7. Weight greater than or equal to 110 pounds (50kg)&#xD;
&#xD;
          8. RPR performed in the 4 months prior to the day of donation and non-reactive.&#xD;
&#xD;
          9. AST performed in the 4 months prior to the day of donation less than 1.5 upper limit&#xD;
             of normal.&#xD;
&#xD;
         10. SARS antibody performed in the 4 months prior to the day of donation, and Ab titer&#xD;
             greater than or equal to 1:80&#xD;
&#xD;
         11. Quantitative immune globulin levels performed in the 4 months prior to the day of&#xD;
             donation (and all of the following):&#xD;
&#xD;
               -  Ig A greater than or equal to 90 mg/dL&#xD;
&#xD;
               -  Ig G greater than or equal to 650 mg/dL&#xD;
&#xD;
               -  Ig M greater than or equal to 35 mg/dL&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
        RECOVERED SARS SCREENING - EXCLUSION CRITERIA:&#xD;
&#xD;
          1. Age less than 18 years old, or greater than 56 years old.&#xD;
&#xD;
          2. Signs of active respiratory infection including cough, dyspnea, or oxygen requirement.&#xD;
&#xD;
          3. Subjective fever in the last 3 days&#xD;
&#xD;
          4. History of headache with fever within the past 7 days.&#xD;
&#xD;
          5. Known history of congestive heart failure, pulmonary hypertension or other diseases in&#xD;
             which the fluid shifts associated with apheresis present more than minimal risk.&#xD;
&#xD;
          6. Known history of bleeding diathesis or therapeutic anticoagulation.&#xD;
&#xD;
          7. Bilateral mastectomy or other relative contraindications to peripheral venous catheter&#xD;
             insertion.&#xD;
&#xD;
          8. Within the last week has:&#xD;
&#xD;
               -  Taken traditional Chinese medicines.&#xD;
&#xD;
               -  Received hepatitis B vaccination.&#xD;
&#xD;
          9. Within the last 3 weeks has:&#xD;
&#xD;
             - Received live-attenuated vaccines such as BCG, yellow fever, measles, mumps,&#xD;
             poliomyelitis (oral), or live attenuated typhoid fever.&#xD;
&#xD;
         10. Within the last 4 weeks has:&#xD;
&#xD;
             - Received rubella or varicella zoster (chicken pox) vaccination.&#xD;
&#xD;
         11. Within the last 6 weeks has:&#xD;
&#xD;
               -  Received standard IVIG for hepatitis A or other indications.&#xD;
&#xD;
               -  Received anti-tetanus toxoid or other passive immunizations with animal serum.&#xD;
&#xD;
               -  Been diagnosed with West Nile virus infection.&#xD;
&#xD;
         12. Within the last 8 weeks:&#xD;
&#xD;
             - Was vaccinated with the small pox vaccine, or was in close contact with someone who&#xD;
             was vaccinated (i.e., close family member).&#xD;
&#xD;
         13. Within the last 3 months has:&#xD;
&#xD;
               -  A history of unexplained weight loss of more than 10 lbs/4.5 kg.&#xD;
&#xD;
               -  Has been seen by a physician or public health staff for investigation of TB.&#xD;
&#xD;
               -  Current or previous participation in any other apheresis procedures/protocols&#xD;
                  (not related to this protocol).&#xD;
&#xD;
         14. Within the last 6 months has had:&#xD;
&#xD;
               -  A diagnosis of Dengue fever.&#xD;
&#xD;
               -  An induced abortion.&#xD;
&#xD;
               -  A blood donation of a double unit of red cells.&#xD;
&#xD;
         15. Within the last 12 months has:&#xD;
&#xD;
               -  Received any blood or blood component.&#xD;
&#xD;
               -  Donated blood at a paid donation center (donations at a hospital blood bank do&#xD;
                  not apply).&#xD;
&#xD;
               -  History of unsafe (multiple-use equipment) tattoo, acupuncture, or piercing&#xD;
                  practices.&#xD;
&#xD;
               -  Received an organ transplant.&#xD;
&#xD;
               -  Received a bone or skin graft.&#xD;
&#xD;
               -  Lived with someone who has any type of hepatitis.&#xD;
&#xD;
               -  Traveled to areas with malaria.&#xD;
&#xD;
               -  Incarcerated for more than 72 hours.&#xD;
&#xD;
               -  Oral or inhalation use of illegal drugs (i.e. those not prescribed by a&#xD;
                  physician).&#xD;
&#xD;
               -  Received hepatitis B IVIG for passive immunity.&#xD;
&#xD;
         16. Within the last 12 months has had sexual contact with (any of the following):&#xD;
&#xD;
               -  An individual having viral hepatitis.&#xD;
&#xD;
               -  A prostitute or anyone else who takes money or drugs or other payment for sex.&#xD;
&#xD;
               -  Anyone who has ever used needles to take drugs, steroids, or anything else not&#xD;
                  prescribed by their doctor.&#xD;
&#xD;
               -  Anyone who has hemophilia or has used clotting factor concentrates.&#xD;
&#xD;
               -  For females, a male who has ever had sexual contact with another male.&#xD;
&#xD;
         17. Within the last 2 years has:&#xD;
&#xD;
             - Has received treatment for tuberculosis.&#xD;
&#xD;
         18. Within the last 3 years:&#xD;
&#xD;
             - Has been diagnosed with malaria.&#xD;
&#xD;
         19. History of cancer that meets any one of the following criteria:&#xD;
&#xD;
               -  Non-melanoma skin cancers within the last 1 year&#xD;
&#xD;
               -  Melanoma or any other cancer (excluding non-melanoma skin cancers).&#xD;
&#xD;
         20. Medication history that includes any of the following:&#xD;
&#xD;
               -  Finasteride (Proscar, Propecia) within the last 1 month.&#xD;
&#xD;
               -  Isotretinoin (Accutane) within the last 1 month.&#xD;
&#xD;
               -  Acitretin (Soriatane) within the last 3 years.&#xD;
&#xD;
               -  Etretinate (Tegison) at any time.&#xD;
&#xD;
               -  Dutasteride (Avodart) within the last 6 months.&#xD;
&#xD;
               -  Viagra within the last week.&#xD;
&#xD;
               -  Growth hormone made from human pituitary glands at any time&#xD;
&#xD;
               -  Any growth hormone administered prior to 1985.&#xD;
&#xD;
               -  Beef insulin from the United Kingdom at any time.&#xD;
&#xD;
               -  Xenical or other weight reduction medications within the last week.&#xD;
&#xD;
         21. Has ever had (any of the following)&#xD;
&#xD;
               -  Known history of HIV.&#xD;
&#xD;
               -  Sexual contact with someone known to have HIV or HTLV.&#xD;
&#xD;
               -  Known history of Hepatitis after the 11th birthday.&#xD;
&#xD;
               -  Had a relative with Creutzfield-Jakob Disease, or been told that this disease is&#xD;
                  inherited within the family.&#xD;
&#xD;
               -  Received blood transfusion in the United Kingdom.&#xD;
&#xD;
               -  History of receiving money, drugs or other payment for sex.&#xD;
&#xD;
               -  History of receiving clotting factor concentrates.&#xD;
&#xD;
               -  History of a dura mater graft.&#xD;
&#xD;
               -  History of babesiosis.&#xD;
&#xD;
               -  For male donors, history of sexual contact with another male.&#xD;
&#xD;
               -  Used needles to take drugs, steroids, or other medications not prescribed by a&#xD;
                  physician.&#xD;
&#xD;
               -  Trypanosomiasis (Chagas' disease and sleeping sickness)&#xD;
&#xD;
               -  Leshmaniasis (Kala-azar)&#xD;
&#xD;
               -  Filariasis&#xD;
&#xD;
               -  Q fever&#xD;
&#xD;
               -  Yaws&#xD;
&#xD;
               -  All venereal diseases (including genital herpes)&#xD;
&#xD;
               -  Sexual contact with anyone who lived in listed African countries after 1977.&#xD;
&#xD;
         22. History of living 3 or more months in the UK from 1980-1996.&#xD;
&#xD;
         23. History of living 5 or more years in Europe since 1980.&#xD;
&#xD;
         24. Currently pregnant (if known).&#xD;
&#xD;
        SARS APHERESIS SCREENING - EXCLUSION CRITERIA:&#xD;
&#xD;
        1. Positive urine pregnancy test.&#xD;
&#xD;
        DAY OF DONATION SCREENING - EXCLUSION CRITERIA:&#xD;
&#xD;
          1. Blood hemoglobin greater than or equal to 17 for males or females.&#xD;
&#xD;
          2. Pilots, fireman, scaffolding workers, divers, bus and truck drivers, crane operators&#xD;
             or underground workers who are on duty or planned to work the day of donation.&#xD;
&#xD;
          3. Planned participation in dangerous sports such as rock climbing, hang gliding, or&#xD;
             scuba-diving the day of donation.&#xD;
&#xD;
          4. Signs/symptoms of an acute respiratory disease.&#xD;
&#xD;
          5. Signs/symptoms of any skin disease at the site of phlebotomy or any such disease&#xD;
             generalized to such an extent as to create a risk of contamination of the plasma.&#xD;
&#xD;
          6. Skin punctures or scars indicative of addiction to self-injected narcotics.&#xD;
&#xD;
          7. Persons with signs of debilitation, under nutrition, plethora, anaemia, jaundice,&#xD;
             cyanosis, dyspnea, or mental instability.\&#xD;
&#xD;
          8. In the opinion of the interviewer, a donor that: (either of the following)&#xD;
&#xD;
               -  appears to be under the influence of any drug or alcohol&#xD;
&#xD;
               -  for any reason does not appear to be providing reliable answers to medical&#xD;
                  history questions&#xD;
&#xD;
          9. Within the last 8 weeks, has not had the red blood cells returned during a&#xD;
             plasmapheresis procedure.&#xD;
&#xD;
         10. Within the last 8 weeks has been a donor of a unit of whole blood.&#xD;
&#xD;
         11. Subjective fever or other symptoms suggestive of active infection.&#xD;
&#xD;
         12. Known exposure (since screening or previous donation) to HIV, Hepatitis B or Hepatitis&#xD;
             C.&#xD;
&#xD;
         13. Received toxoid, killed vaccines, or recombinant vaccines such as cholera, typhoid,&#xD;
             diphtheria, tetanus, hepatitis A, influenza, poliomyelitis (injection), or pertussis&#xD;
             within the last 24 hours.&#xD;
&#xD;
         14. Received live-attenuated vaccines such as BCG, yellow fever, measles, mumps,&#xD;
             poliomyelitis (oral), or live attenuated typhoid fever within the last 3 weeks.&#xD;
&#xD;
         15. Received rubella or varicella zoster (chicken pox) vaccination within the last 4&#xD;
             weeks.&#xD;
&#xD;
         16. Current or previous participation (within the last 3 months) in any other apheresis&#xD;
             procedures/protocols (i.e. not related to this protocol).&#xD;
&#xD;
         17. Known or suspected pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <reference>
    <citation>Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, St√∂hr K, Osterhaus AD. Aetiology: Koch's postulates fulfilled for SARS virus. Nature. 2003 May 15;423(6937):240.</citation>
    <PMID>12748632</PMID>
  </reference>
  <verification_date>February 8, 2007</verification_date>
  <study_first_submitted>June 19, 2006</study_first_submitted>
  <study_first_submitted_qc>June 19, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2006</study_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <keyword>IVIG</keyword>
  <keyword>Plasmapheresis</keyword>
  <keyword>Blood Collection</keyword>
  <keyword>Immune Globulin</keyword>
  <keyword>Severe Acute Respiratory Syndrome</keyword>
  <keyword>SARS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

